John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 38 years experience in U.S. FDA-regulated industries, 24 as an independent consultant. John has worked with companies from start-up to Fortune 100, world wide. He specializes in quality assuranc Read more
The verification and validation of medical industry software is coming under increased scruinty by the U.S. FDA. This webinar will address the use of the FDA, GAMP,EN/ IEC 62304, 21 CFR 11, and other applicable industry software validation models, coupled with the ISO 14971 / ICH Q9 Risk Management models, and their real-world implementation.
Why Should You Attend:
Software has become pervasive in medical devices themselves, and in the controlling, running and monitoring of medical product processes, whether they be in the pharmaceutical, medical device, biologics or dietary supplements industries. A quick review of Internet forums will show much confusion about the subject. Software is being developed for medical imaging, and even thought control of computers. It is increasingly being used for e-records and e-signatures. The U.S. FDA rightly recognizes that virtually all software quality problems occur in the design, testing and validation phases, since replication of software is relatively defect-free. Regulatory auditors are more comfortable with delving into software isssues. Effective and real world software V&V is even more important in today’s resource constrained industrial environment. This discussion will focus on a preferred U.S. FDA documentation "model" -- the 11 key documents in a V&V Report -- in various applications, including ERP, in-device, as-device, process/equipment control, and cGMP data / Part 11 applications.
Course Objectives:
The verification and validation of medical software is coming under increased scruinty by the U.S. FDA. This webinar will address the use of the FDA, GAMP, 21 CFR Part 11, "Electronic Records" / "Electronic Signatures", and other applicable industry software validation models, coupled with the ISO 14971 / ICH Q9 Product Risk Management models, to plan, structure, run, and document acceptable software validations. The FDA and other regulatory agencies have stated that software validation can only be accomplished effectively if “risk-based”. How can this be done in the "real world".
This webinar will address software that is:
1) As-Product;
2) In-Product;
3) Process and/or In Production and Test Equipment; and
4) The Quality System / CGMPs.
A manufacturer is responsible to identify these requirements and implement them into an effective software V&V process.
Course Outline:
• Verification or Validation -- FDA Expectations
• The Project Validation Plan
• An FDA-accepted Documentation "Model"
• Product and Process / Test / Facilities / Equipment Software V&V
• When and How to Use DQ, IQ, OQ, PQ (or their equivalents)
• EN 62304 / GAMP / Other Considerations
• The FDA’s 11 Key V&V Documentation Elements
• “White Box” and “Black Box” Validations
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
Senior management in Drugs, Devices, Combination Products, Biologics, Dietary Supplements
• QA / RA
• Software development, programming, documentation, testing teams
• R&D
• Engineering
• Production
• Operations
• Consultants; others tasked with product, process, electronic records software V&V responsibilities
6-Hour Virtual Seminar on Computer System Validation for Cloud and COTS Applications
LIVE : Scheduled on
17-May-2024 :11:00 AM EDT
|
2-hr Virtual Seminar: FDA Inspections - Understanding the Core Elements
LIVE : Scheduled on
20-May-2024 :01:00 PM EDT
|
21 CFR 58 - Good Laboratory Practice (GLP) and USP 1058 Validations
LIVE : Scheduled on
30-May-2024 :01:00 PM EDT
|
6-Hour Virtual Seminar - Death by CAPA - Does your CAPA Program need a CAPA?
LIVE : Scheduled on
18-June-2024 :11:00 AM EDT
|
6-Hour Virtual Seminar on 21 CFR Part 11 Compliance for Computer Systems Regulated by FDA
LIVE : Scheduled on
19-June-2024 :11:00 AM EDT
|